FibroBiologics, Inc. Common Stock (FBLG NASDAQ) stock market data APIs
$0.2773
-0.02(-7.2%)
as of December 8, 2025
Try our APIs with
free plan!
FibroBiologics, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Prev. Close
0.2773
Open
0.2622
High
0.286
Low
0.2537
52 wk Range
0.24-2.541
Market Cap
16 966 K
Shares Outstanding
61 292 K
EPS
-0.13
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with FibroBiologics, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get FibroBiologics, Inc. Common Stock data using free add-ons & libraries
Get FibroBiologics, Inc. Common Stock Fundamental Data
FibroBiologics, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -17 546 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-31
- EPS/Forecast: -0.115
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
FibroBiologics, Inc. Common Stock News
New
FibroBiologics announces payoff of outstanding debt
* FibroBiologics (FBLG [https://seekingalpha.com/symbol/FBLG]) said on Wednesday that it has paid all amounts outstanding [https://seekingalpha.com/pr/20321143-fibrobiologics-announces-payoff-of-out...
FibroBiologics Announces Payoff of Outstanding Debt
HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pendin...
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pendin...
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pendin...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
